Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
12-16 May, 2025
BioProcess Internation...BioProcess International Europe
Not Confirmed
Not Confirmed
12-15 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
12-16 May, 2025
BioProcess Internation...BioProcess International Europe
Industry Trade Show
Not Confirmed
12-15 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
09 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/icotrokinra-results-show-significant-skin-clearance-in-patients-with-difficult-to-treat-scalp-and-genital-psoriasis-302450309.html
06 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/jj-gene-therapy-fails-improve-visual-navigation-late-stage-rare-eye-disease-trial
05 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/after-striking-out-bankruptcy-court-johnson-johnson-goes-after-expert-witness-talc-cases
02 May 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/jj-backed-histosonics-explores-sale-25-billion-valuation-ft-reports-2025-05-02/
01 May 2025
// PRESS RELEASE
https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-receives-FDA-approval-for-IMAAVY-nipocalimab-aahu-a-new-FcRn-blocker-offering-long-lasting-disease-control-in-the-broadest-population-of-people-living-with-generalized-myasthenia-gravis-gMG/default.aspx
28 Apr 2025
// GLOBENEWSIRE
https://www.globenewswire.com/news-release/2025/04/26/3068774/0/en/Johnson-Johnson-s-TAR-200-monotherapy-achieves-high-disease-free-survival-of-more-than-80-percent-in-BCG-unresponsive-high-risk-papillary-NMIBC.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Johnson & Johnson is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Nicotine bulk with DMF offered by Johnson & Johnson
Find a price of Naloxone Hydrochloride bulk offered by Johnson & Johnson
Find a price of Sodium Hyaluronate bulk offered by Johnson & Johnson